Cited by 2,070T-cell and B-cell ImmunologyCancer Immunotherapy and BiomarkersHIV Research and Treatment

The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.

Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy

Open access

Im, Se Jin, Hashimoto, Masao, Gerner, Michael Y., Lee, Junghwa, Kissick, Haydn T., Burger, Matheus C., Shan, Qiang, Hale, J. Scott, Lee, Judong, Nasti, Tahseen H., Sharpe, Arlene H., Freeman, Gordon J., Germain, Ronald N., Nakaya, Helder I., Xue, Hai-Hui, Ahmed, Rafi·2016·Nature

DOI 10.1038/nature19330PMC PMC5297183

Open this paper in CoChat — free account

Abstract

Chronic viral infections are characterized by a state of CD8+ T-cell dysfunction that is associated with expression of the programmed cell death 1 (PD-1) inhibitory receptor. A better understanding of the mechanisms that regulate CD8+ T-cell responses during chronic infection is required to improve immunotherapies that restore function in exhausted CD8+ T cells. Here we identify a population of virus-specific CD8+ T cells that proliferate after blockade of the PD-1 inhibitory pathway in mice chronically infected with lymphocytic choriomeningitis virus (LCMV). These LCMV-specific CD8+ T cells expressed the PD-1 inhibitory receptor, but also expressed several costimulatory molecules such as ICOS and CD28. This CD8+ T-cell subset was characterized by a unique gene signature that was related to that of CD4+ T follicular helper (T FH) cells, CD8+ T cell memory precursors and haematopoietic stem cell progenitors, but that was distinct from that of CD4+ T H 1 cells and CD8+ terminal effectors. This CD8+ T-cell population was found only in lymphoid tissues and resided predominantly in the T-cell zones along with naive CD8+ T cells. These PD-1+CD8+ T cells resembled stem cells during chronic LCMV infection, undergoing self-renewal and also differentiating into the terminally exhausted CD8+ T cells that were present in both lymphoid and non-lymphoid tissues. The proliferative burst after PD-1 blockade came almost exclusively from this CD8+ T-cell subset. Notably, the transcription factor TCF1 had a cell-intrinsic and essential role in the generation of this CD8+ T-cell subset. These findings provide a better understanding of T-cell exhaustion and have implications in the optimization of PD-1-directed immunotherapy in chronic infections and cancer.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/nature19330

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Toll-Like Receptors
Takeda, K., Kaisho, T., & Akira, S. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141126 · Cited by 6,143
The future of immune checkpoint therapy
Sharma, P., & Allison, J. P. (2015) · Science · doi:10.1126/science.aaa8172 · Cited by 4,878
Restoring function in exhausted CD8 T cells during chronic viral infection
Barber, D. L., Wherry, E. J., Masopust, D., Zhu, B., Allison, J. P., Sharpe, A. H., Freeman, G. J., & Ahmed, R. (2005) · Nature · doi:10.1038/nature04444 · Cited by 4,057
Self-citation
Follicular Helper CD4 T Cells (T FH )
Crotty, S. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-031210-101400 · Cited by 2,738
A role for Wnt signalling in self-renewal of haematopoietic stem cells
Reya, T., Duncan, A. W., Ailles, L., Domen, J., Scherer, D. C., Willert, K., Hintz, L., Nusse, R., & Weissman, I. L. (2003) · Nature · doi:10.1038/nature01593 · Cited by 2,159
Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection
Blackburn, S. D., Shin, H., Haining, W. N., Zou, T., Workman, C. J., Polley, A., Betts, M. R., Freeman, G. J., Vignali, D. A. A., & Wherry, E. J. (2009) · Nature Immunology · doi:10.1038/ni.1679 · Cited by 2,062
Self-citation
Viral Immune Evasion Due to Persistence of Activated T Cells Without Effector Function
Zajac, A. J., Blattman, J. N., Murali-Krishna, K., Sourdive, D. J. D., Suresh, M., Altman, J. D., & Ahmed, R. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.12.2205 · Cited by 1,978
Self-citation
Counting Antigen-Specific CD8 T Cells: A Reevaluation of Bystander Activation during Viral Infection
Murali‐Krishna, K., Altman, J. D., Suresh, M., Sourdive, D. J. D., Zajac, A. J., Miller, J. D., Slansky, J. E., & Ahmed, R. (1998) · Immunity · doi:10.1016/s1074-7613(00)80470-7 · Cited by 1,918
Self-citation
Inflammation Directs Memory Precursor and Short-Lived Effector CD8+ T Cell Fates via the Graded Expression of T-bet Transcription Factor
Joshi, N. S., Cui, W., Chandele, A., Lee, H. K., Urso, D. R., Hagman, J., Gapin, L., & Kaech, S. M. (2007) · Immunity · doi:10.1016/j.immuni.2007.07.010 · Cited by 1,861
Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease
Monney, L., Sabatos, C. A., Gaglia, J. L., Ryu, A., Waldner, H., Chernova, T., Manning, S., Greenfield, E. A., Coyle, A. J., Sobel, R. A., et al. (2002) · Nature · doi:10.1038/415536a · Cited by 1,677
Self-citation

Show all 37 references

Sorted by citations

Items 601–700 of 1,003

Chronic antigen in solid tumors drives a distinct program of T cell residence
Gavil, N. V., Scott, M. C., Weyu, E., Smith, O. C. G., O’Flanagan, S. D., Wijeyesinghe, S., Lotfi‐Emran, S., Shiao, S. L., Vezys, V., & Masopust, D. (2023) · Science Immunology · doi:10.1126/sciimmunol.add5976 · Cited by 53
Continuous expression of TOX safeguards exhausted CD8 T cell epigenetic fate
Huang, Y., Ngiow, S. F., Baxter, A. E., Manne, S., Park, S. L., Wu, J. E., Khan, O., Giles, J. R., & Wherry, E. J. (2025) · Science Immunology · doi:10.1126/sciimmunol.ado3032 · Cited by 57
Aptamer‑T Cell Targeted Therapy for Tumor Treatment Using Sugar Metabolism and Click Chemistry
Liu, C.-G., Wang, Y., Liu, P., Yao, Q., Zhou, Y., Li, C., Zhao, Q., Liu, G., & Zhang, X. (2020) · ACS Chemical Biology · doi:10.1021/acschembio.0c00164 · Cited by 53
Mechanisms Governing Immunotherapy Resistance in Pancreatic Ductal Adenocarcinoma
Schmiechen, Z. C., & Stromnes, I. M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.613815 · Cited by 56
Regulation of activated T cell survival in rheumatic autoimmune diseases
Rosetti, F., Madera-Salcedo, I. K., Rodríguez‐Rodríguez, N., & Crispín, J. C. (2022) · Nature Reviews Rheumatology · doi:10.1038/s41584-021-00741-9 · Cited by 54
Combinatorial blockade for cancer immunotherapy: targeting emerging immune checkpoint receptors
Roy, D., Gilmour, C., Patnaik, S., & Wang, L. L. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1264327 · Cited by 53
B cells promote CD8 T cell primary and memory responses to subunit vaccines
Klarquist, J. S., Cross, E. W., Thompson, S. B., Willett, B., Aldridge, D. L., Caffrey-Carr, A. K., Xu, Z., Hunter, C. A., Getahun, A., & Kedl, R. M. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109591 · Cited by 52
Lung dendritic cells migrate to the spleen to prime long-lived TCF1 hi memory CD8 + T cell precursors after influenza infection
Jenkins, M. M., Bachus, H., Botta, D., Schultz, M. D., Rosenberg, A. F., León, B., & Ballesteros‐Tato, A. (2021) · Science Immunology · doi:10.1126/sciimmunol.abg6895 · Cited by 52
Stem cell like memory T cells: A new paradigm in cancer immunotherapy
Wang, F., Cheng, F., & Fang, Z. (2022) · Clinical Immunology · doi:10.1016/j.clim.2022.109078 · Cited by 53
Graft-versus-host disease is locally maintained in target tissues by resident progenitor-like T cells
Sacirbegovic, F., Günther, M., Greco, A., Zhao, D., Wang, X., Zhou, M., Rosenberger, S., Oberbarnscheidt, M. H., Held, W., McNiff, J. M., et al. (2023) · Immunity · doi:10.1016/j.immuni.2023.01.003 · Cited by 54
Immunometabolism of CD8+ T cell differentiation in cancer
Shi, H., Chen, S., & Chi, H. (2024) · Trends in cancer · doi:10.1016/j.trecan.2024.03.010 · Cited by 58
Epigenetic tuning of PD-1 expression improves exhausted T cell function and viral control
Weiss, S. A., Huang, A. Y., Fung, M. E., Martínez, D., Chen, C.-Y., LaSalle, T. J., Miller, B. C., Scharer, C. D., Hegde, M., Nguyen, T. H., et al. (2024) · Nature Immunology · doi:10.1038/s41590-024-01961-3 · Cited by 56
Self-citation
Coexpression of Inhibitory Receptors Enriches for Activated and Functional CD8+ T Cells in Murine Syngeneic Tumor Models
Xiong, H., Mittman, S., Rodriguez, R., Pacheco-Sanchez, P., Москаленко, М., Yang, Y., Elstrott, J., Ritter, A. T., Müller, S., Nickles, D., et al. (2019) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-18-0750 · Cited by 53
Checkpoint inhibitor-related renal vasculitis and use of rituximab
Mamlouk, O., Lin, J. S., Abdelrahim, M., Tchakarov, A. S., Glass, W. F., Selamet, U., Buni, M., Abdel‐Wahab, N., & Abudayyeh, A. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-000750 · Cited by 52
The costimulatory activity of Tim-3 requires Akt and MAPK signaling and its recruitment to the immune synapse
Kataoka, S., Manandhar, P., Lee, J., Workman, C. J., Banerjee, H., Szymczak-Workman, A. L., Kvorjak, M., Lohmueller, J. J., & Kane, L. (2021) · Science Signaling · doi:10.1126/scisignal.aba0717 · Cited by 52
Self-citation
Tissue-resident memory CD8+ T cells in cancer immunology and immunotherapy
Wang, T., Shen, Y., Luyten, S., Yang, Y., & Jiang, X. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104876 · Cited by 53
IL-7R licenses a population of epigenetically poised memory CD8 + T cells with superior antitumor efficacy that are critical for melanoma memory
Micevic, G., Daniels, A., Karlsen, K. F., Park, K., Talty, R., McGeary, M. K., Mirza, H., Blackburn, H. N., Sefik, E., Cheung, J. F., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2304319120 · Cited by 49
Mitochondrial metabolic flexibility is critical for CD8 + T cell antitumor immunity
Chen, C., Zheng, H., Horwitz, E. M., Ando, S., Araki, K., Zhao, P., Li, Z., Ford, M. L., Ahmed, R., & Qu, C. (2023) · Science Advances · doi:10.1126/sciadv.adf9522 · Cited by 49
Self-citation
Primary and Acquired Resistance to Immunotherapy with Checkpoint Inhibitors in NSCLC: From Bedside to Bench and Back
Mariniello, A., Borgeaud, M., WEINER, M. H., Frisone, D., Kim, F., & Addeo, A. (2025) · BioDrugs · doi:10.1007/s40259-024-00700-2 · Cited by 61
Succinate preserves CD8+ T cell fitness to augment antitumor immunity
Ma, K., Cheng, H., Wang, L., Xiao, H., Liu, F., Yang, Y. T., Xiao, Z., Tang, K., Li, S., Wang, G., et al. (2025) · Immunity · doi:10.1016/j.immuni.2025.07.017 · Cited by 57
Use of Mass Cytometry to Profile Human T Cell Exhaustion
Winkler, F., & Bengsch, B. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2019.03039 · Cited by 54
Blocking of the PD-1/PD-L1 interaction by a novel cyclic peptide inhibitor for cancer immunotherapy
Zhai, W., Zhou, X., Zhai, M., Li, W., Ran, Y., Sun, Y., Du, J., Zhao, W., Xing, L., Qi, Y., et al. (2020) · Science China Life Sciences · doi:10.1007/s11427-020-1740-8 · Cited by 53
Checkpoint blockade-induced CD8+ T cell differentiation in head and neck cancer responders
Zhou, L., Zeng, Z., Egloff, A. M., Zhang, F., Guo, F., Campbell, K. M., Du, P. P., Fu, J., Zolkind, P., Ma, X., et al. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-004034 · Cited by 49
The double-edged sword: Harnessing PD-1 blockade in tumor and autoimmunity
Kuchroo, J. R., Hafler, D. A., Sharpe, A. H., & Lucca, L. E. (2021) · Science Immunology · doi:10.1126/sciimmunol.abf4034 · Cited by 51
Self-citation
The paradox of immune checkpoint inhibition re-activating tuberculosis
Ahmed, M. I. M., Tezera, L. B., Elkington, P. T., & Leslie, A. J. (2022) · European Respiratory Journal · doi:10.1183/13993003.02512-2021 · Cited by 53
Peptide vaccine-treated, long-term surviving cancer patients harbor self-renewing tumor-specific CD8+ T cells
Mizukoshi, E., Nakagawa, H., Tamai, T., Kitahara, M., Fushimi, K., Nio, K., Terashima, T., Iida, N., Arai, K., Yamashita, T., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30861-z · Cited by 50
Deficiency of metabolic regulator PKM2 activates the pentose phosphate pathway and generates TCF1+ progenitor CD8+ T cells to improve immunotherapy
Markowitz, G. J., Ban, Y., Tavarez, D. A., Yoffe, L., Podaza, E., He, Y., Martin, M. T., Crowley, M. J. P., Sandoval, T. A., Gao, D., et al. (2024) · Nature Immunology · doi:10.1038/s41590-024-01963-1 · Cited by 60
The Role of WNT Signaling in Mature T Cells: T Cell Factor Is Coming Home
van Loosdregt, J., & Coffer, P. J. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1800633 · Cited by 50
The emerging role of T follicular helper (TFH) cells in aging: Influence on the immune frailty
Varricchi, G., Bencivenga, L., Poto, R., Pecoraro, A., Shamji, M. H., & Rengo, G. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101071 · Cited by 54
Stem cell-like memory T cells: The generation and application
Wang, Y., Qiu, F., Xu, Y., Hou, X., Zhang, Z., Huang, L., Wang, H., Xing, H., & Wu, S. (2021) · Journal of Leukocyte Biology · doi:10.1002/jlb.5mr0321-145r · Cited by 49
Cytolytic CD8 + T cells infiltrate germinal centers to limit ongoing HIV replication in spontaneous controller lymph nodes
Collins, D. R., Hitschfel, J., Urbach, J. M., Mylvaganam, G., Ly, N. L., Arshad, U., Racenet, Z. J., Yanez, A. G., Diefenbach, T. J., & Walker, B. D. (2023) · Science Immunology · doi:10.1126/sciimmunol.ade5872 · Cited by 50
Preclinical study and phase II trial of adapting low-dose radiotherapy to immunotherapy in small cell lung cancer
Wang, H., Yao, Z., Kang, K., Zhou, L., Xiu, W., Sun, J., Xie, C., Yu, M., Li, Y., Zhang, Y., et al. (2024) · Med · doi:10.1016/j.medj.2024.06.002 · Cited by 50
TIGIT and PD-L1 co-blockade promotes clonal expansion of multipotent, non-exhausted antitumor T cells by facilitating co-stimulation
Nutsch, K., Banta, K. L., Wu, T. D., Tran, C. W., Mittman, S., Duong, E., Nabet, B. Y., Qu, Y., Williams, K., Müller, S., et al. (2024) · Nature Cancer · doi:10.1038/s43018-024-00870-6 · Cited by 57
Low-avidity T cells drive endogenous tumor immunity in mice and humans
Singhaviranon, S., Dempsey, J. P., Hagymasi, A. T., Măndoiu, I., & Srivastava, P. K. (2025) · Nature Immunology · doi:10.1038/s41590-024-02044-z · Cited by 53
EZH2 as a Regulator of CD8+ T Cell Fate and Function
Stairiker, C. J., Thomas, G. D., & Salek‐Ardakani, S. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.593203 · Cited by 49
Immunometabolism in the Tumor Microenvironment
Roy, D. G., Kaymak, I., Williams, K. S., Ma, E. H., & Jones, R. G. (2020) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030518-055817 · Cited by 49
A Subset of Localized Prostate Cancer Displays an Immunogenic Phenotype Associated with Losses of Key Tumor Suppressor Genes
Calagua, C., Ficial, M., Jansen, C. S., Hirz, T., del Balzo, L., Wilkinson, S. C., Lake, R. G., Ku, A. T., Voznesensky, O. S., Sykes, D. B., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-0121 · Cited by 52
Self-citation
Clinical and molecular characteristics associated with response to therapeutic PD-1/PD-L1 inhibition in advanced Merkel cell carcinoma
Spassova, I., Ugurel, S., Kubat, L., Zimmer, L., Terheyden, P. A. M., Mohr, A., Bjorn-Andtback, H., Villabona, L. E. E., Leiter, U., Eigentler, T., et al. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-003198 · Cited by 48
The role of CD4+ T cells in tumor and chronic viral immune responses
Xie, L., Fang, J., Yu, J., Zhang, W., He, Z., Ye, L., & Wang, H. (2023) · MedComm · doi:10.1002/mco2.390 · Cited by 54
TCF1–LEF1 co-expression identifies a multipotent progenitor cell (TH2-MPP) across human allergic diseases
Kratchmarov, R., Djeddi, S., Dunlap, G. S., He, W., Jia, X., Burk, C. M., Ryan, T., McGill, A., Allegretti, J. R., Kataru, R. P., et al. (2024) · Nature Immunology · doi:10.1038/s41590-024-01803-2 · Cited by 52
LRIG1 engages ligand VISTA and impairs tumor-specific CD8 + T cell responses
Ta, H. M., Roy, D., Zhang, K., Alban, T. J., Jurić, I., Dong, J., Parthasarathy, P. B., Patnaik, S., Delaney, E., Gilmour, C., et al. (2024) · Science Immunology · doi:10.1126/sciimmunol.adi7418 · Cited by 52
A dynamical motif comprising the interactions between antigens and CD8 T cells may underlie the outcomes of viral infections
Baral, S., Antia, R., & Dixit, N. M. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1902178116 · Cited by 46
Discovery of Small Molecules for the Reversal of T Cell Exhaustion
Marro, B. S., Žák, J., Zavareh, R. B., Teijaro, J. R., Lairson, L. L., & Oldstone, M. B. A. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.10.119 · Cited by 47
Immunologic characteristics of HIV ‐infected individuals who make broadly neutralizing antibodies
Borrow, P., & Moody, M. A. (2017) · Immunological Reviews · doi:10.1111/imr.12504 · Cited by 49
Immune Cell Dynamics in Rhesus Macaques Infected with a Brazilian Strain of Zika Virus
Silveira, E. L. V., Rogers, K. A., Gumber, S., Amancha, P. K., Xiao, P., Woollard, S. M., Byrareddy, S. N., Teixeira, M. M., & Villinger, F. J. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1700256 · Cited by 47
Coagulation signaling and cancer immunotherapy
Ruf, W., & Graf, C. (2020) · Thrombosis Research · doi:10.1016/s0049-3848(20)30406-0 · Cited by 47
Exhaustion in tumor-infiltrating Mucosal-Associated Invariant T (MAIT) cells from colon cancer patients
Rodin, W. C. I., Sundström, P., Ahlmanner, F., Szeponik, L., Zajt, K. K., Wettergren, Y., Lindskog, E. B., & Quiding‐Järbrink, M. (2021) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-021-02939-y · Cited by 46
A Phase II Window of Opportunity Study of Neoadjuvant PD-L1 versus PD-L1 plus CTLA-4 Blockade for Patients with Malignant Pleural Mesothelioma
Lee, H., Jang, H.-J., Ramineni, M., Wang, D. Y., Ramos, D., Choi, J. M., Splawn, T. G., Espinoza, M., Almarez, M., Hosey, L., et al. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-22-2566 · Cited by 48
Harnessing IL-2 for immunotherapy against cancer and chronic infection: a historical perspective and emerging trends
Im, S. J., Lee, K., & Ha, S. (2024) · Experimental & Molecular Medicine · doi:10.1038/s12276-024-01301-3 · Cited by 51
Self-citation
Spatial dynamics of CD39+CD8+ exhausted T cell reveal tertiary lymphoid structures-mediated response to PD-1 blockade in esophageal cancer
Tanoue, K., Ohmura, H., Uehara, K., Ito, M., Yamaguchi, T., Tsuchihashi, K., Shinohara, Y., Lu, P., Tamura, S., Shimokawa, H., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-53262-w · Cited by 51
PD-1 Dynamically Regulates Inflammation and Development of Brain-Resident Memory CD8 T Cells During Persistent Viral Encephalitis
Shwetank, Frost, E. L., Mockus, T. E., Ren, H. M., Toprak, M., Lauver, M. D., Netherby, C. S., Jin, G., Cosby, J., Evavold, B. D., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00783 · Cited by 47
Tumor endothelial cell‐induced CD8+ T‐cell exhaustion via GPNMB in hepatocellular carcinoma
Sakano, Y., Noda, T., Kobayashi, S., Sasaki, K., Iwagami, Y., Yamada, D., Tomimaru, Y., Akita, H., Gotoh, K., Takahashi, H., et al. (2022) · Cancer Science · doi:10.1111/cas.15331 · Cited by 46
The engineered CD80 variant fusion therapeutic davoceticept combines checkpoint antagonism with conditional CD28 costimulation for anti-tumor immunity
Maurer, M. F., Lewis, K. E., Kuijper, J. L., Ardourel, D., Gudgeon, C. J., Chandrasekaran, S., Mudri, S., Kleist, K. N., Navas, C. L., Wolfson, M. F., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29286-5 · Cited by 46
Vax-Innate: improving therapeutic cancer vaccines by modulating T cells and the tumour microenvironment
Baharom, F., Hermans, D., Delamarre, L., & Seder, R. A. (2024) · Nature reviews. Immunology · doi:10.1038/s41577-024-01091-9 · Cited by 47
Inhibitory PD-1 axis maintains high-avidity stem-like CD8+ T cells
Hor, J. L., Schrom, E. C., Wong-Rolle, A., Vistain, L. F., Shang, W., Dong, Q., Zhao, C. N., Jin, C., & Germain, R. N. (2025) · Nature · doi:10.1038/s41586-025-09440-x · Cited by 56
Self-citation
Transcriptional and epigenetic regulation of T cell hyporesponsiveness
Pereira, R. M., Hogan, P. G., Rao, A., & Martínez, G. (2017) · Journal of Leukocyte Biology · doi:10.1189/jlb.2ri0317-097r · Cited by 50
Tcf1+ cells are required to maintain the inflationary T cell pool upon MCMV infection
Welten, S. P. M., Yermanos, A., Baumann, N. S., Wagen, F., Oetiker, N., Sandu, I., Pedrioli, A., Oduro, J. D., Reddy, S. T., Čičin‐Šain, L., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16219-3 · Cited by 47
STARTRAC analyses of scRNAseq data from tumor models reveal T cell dynamics and therapeutic targets
Bhatt, D. M., Kang, B., Sawant, D. V., Zheng, L., Perez, K. C., Huang, Z., Sekirov, L., Wolak, D. J., Huang, J. Y., Liu, X., et al. (2021) · The Journal of Experimental Medicine · doi:10.1084/jem.20201329 · Cited by 45
Secondary infections rejuvenate the intestinal CD103+tissue-resident memory T cell pool
von Hoesslin, M., Kuhlmann, M., de Almeida, G. P., Kanev, K., Wurmser, C., Gerullis, A.-K., Roelli, P., Berner, J., & Zehn, D. (2022) · Science Immunology · doi:10.1126/sciimmunol.abp9553 · Cited by 44
Stepwise differentiation of follicular helper T cells reveals distinct developmental and functional states
Podestà, M. A., Cavazzoni, C. B., Hanson, B. L., Bechu, E. D., Ralli, G., Clement, R. L., Zhang, H., Chandrakar, P., Lee, J.-M., Robles, T. R., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-43427-4 · Cited by 47
Self-citation
Stem-like memory and precursors of exhausted T cells share a common progenitor defined by ID3 expression
de Graça, C. G., Sheikh, A. A., Newman, D. M., Wen, L., Li, S. F., Shen, J., Zhang, Y., Gabriel, S. S., Chisanga, D., Seow, J. J. W., et al. (2025) · Science Immunology · doi:10.1126/sciimmunol.adn1945 · Cited by 45
Efficacy of Immune Checkpoint Inhibitor Monotherapy for Advanced Non-Small-Cell Lung Cancer with ALK Rearrangement
Oya, Y., Kuroda, H., Nakada, T., Takahashi, Y., Sakakura, N., & Hida, T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072623 · Cited by 46
Expanding the Role for Immunotherapy in Triple-Negative Breast Cancer
Savas, P. S., & Loi, S. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.04.007 · Cited by 45
Quality of CD8 + T cell immunity evoked in lymph nodes is compartmentalized by route of antigen transport and functional in tumor context
O’Melia, M. J., Rohner, N. A., Manspeaker, M. P., Francis, D. M., Kissick, H. T., & Thomas, S. N. (2020) · Science Advances · doi:10.1126/sciadv.abd7134 · Cited by 47
Self-citation
The intratumoral CXCR3 chemokine system is predictive of chemotherapy response in human bladder cancer
Vollmer, T., Schlickeiser, S., Amini, L., Schulenberg, S., Wendering, D. J., Banday, V. S., Jurisch, A., Noster, R., Kunkel, D., Brindle, N. R., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abb3735 · Cited by 44
Reversing T-cell exhaustion in immunotherapy: a review on current approaches and limitations
Tabana, Y., Moon, T. C., Siraki, A. G., Elahi, S., & Barakat, K. (2021) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2021.1937123 · Cited by 47
The Yin and Yang of Type I IFNs in Cancer Promotion and Immune Activation
Musella, M., Galassi, C., Manduca, N., & Sistigu, A. (2021) · Biology · doi:10.3390/biology10090856 · Cited by 45
Schrödinger’s T Cells: Molecular Insights Into Stemness and Exhaustion
Gonzalez, N. M., Zou, D., Gu, A., & Chen, W. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.725618 · Cited by 46
T-Cell Aging-Associated Phenotypes in Autoimmune Disease
Zhao, T. V., Sato, Y., Goronzy, J. J., & Weyand, C. M. (2022) · Frontiers in Aging · doi:10.3389/fragi.2022.867950 · Cited by 50
CXCR3 regulates stem and proliferative CD8+ T cells during chronic infection by promoting interactions with DCs in splenic bridging channels
Bangs, D. J., Tsitsiklis, A., Steier, Z., Chan, S. W., Kaminski, J., Streets, A., Yosef, N., & Robey, E. A. (2022) · Cell Reports · doi:10.1016/j.celrep.2021.110266 · Cited by 44
Reframing How Physical Activity Reduces The Incidence of Clinically-Diagnosed Cancers: Appraising Exercise-Induced Immuno-Modulation As An Integral Mechanism
Emery, A., Moore, S. E., Turner, J. E., & Campbell, J. P. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.788113 · Cited by 49
Phenotypic CD8 T cell profiling in chronic hepatitis B to predict HBV-specific CD8 T cell susceptibility to functional restoration in vitro
Rossi, M., Vecchi, A. L., Tiezzi, C., Barili, V., Fisicaro, P., Penna, A., Montali, I., Daffis, S., Fletcher, S. P., Gaggar, A., et al. (2023) · Gut · doi:10.1136/gutjnl-2022-327202 · Cited by 44
Exhausted T cells hijacking the cancer-immunity cycle: Assets and liabilities
Brunell, A. E., Lahesmaa, R., Autio, A. K., & Thotakura, A. K. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1151632 · Cited by 46
Lymph nodes: at the intersection of cancer treatment and progression
Reticker-Flynn, N. E., & Engleman, E. G. (2023) · Trends in Cell Biology · doi:10.1016/j.tcb.2023.04.001 · Cited by 45
A bright future: Advanced nanotechnology-assisted microwave therapy
Du, Y., Zhou, J., He, F., Zang, P., Gong, H., Liu, C., & Yang, P. (2023) · Nano Today · doi:10.1016/j.nantod.2023.101963 · Cited by 44
CD28/PD1 co-expression: dual impact on CD8+ T cells in peripheral blood and tumor tissue, and its significance in NSCLC patients' survival and ICB response
Palermo, B., Franzese, O., Frisullo, G., D’Ambrosio, L., Panetta, M., Campo, G., D’Andrea, D., Sperduti, I., Nicola, F. D., Goeman, F., et al. (2023) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02846-3 · Cited by 46
Strategies to overcome HBV-specific T cell exhaustion: checkpoint inhibitors and metabolic re-programming
Fisicaro, P., Boni, C., Barili, V., Laccabue, D., & Ferrari, C. I. (2018) · Current Opinion in Virology · doi:10.1016/j.coviro.2018.01.003 · Cited by 44
The potential predictive value of circulating immune cell ratio and tumor marker in atezolizumab treated advanced non-small cell lung cancer patients
Zhuo, M., Chen, H., Zhang, T., Yang, X., Zhong, J., Wang, Y., An, T., Wu, M., Wang, Z., Huang, J., et al. (2018) · Cancer Biomarkers · doi:10.3233/cbm-171089 · Cited by 42
Epidermal growth factor induces STAT1 expression to exacerbate the IFNr‐mediated PD‐L1 axis in epidermal growth factor receptor‐positive cancers
Cheng, C., Lin, H., Tsai, K.-J., Chiang, Y., Lim, K., Chen, C. G., Su, Y., Peng, C., Ho, A., Huang, L., et al. (2018) · Molecular Carcinogenesis · doi:10.1002/mc.22881 · Cited by 44
Immune Exhaustion: Past Lessons and New Insights from Lymphocytic Choriomeningitis Virus
Kahan, S. M., & Zajac, A. J. (2019) · Viruses · doi:10.3390/v11020156 · Cited by 44
Type I IFNs and CD8 T cells increase intestinal barrier permeability after chronic viral infection
Labarta-Bajo, L., Nilsen, S. P., Humphrey, G., Schwartz, T., Sanders, K., Swafford, A. D.-E., Knight, R. D., Turner, J. R., & Zúñiga, E. I. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20192276 · Cited by 42
T cell-based cancer immunotherapy: opportunities and challenges
Ma, K., Xu, Y., Cheng, H., Tang, K., Ma, J., & Huang, B. (2025) · 中国科学通报：英文版 · doi:10.1016/j.scib.2025.03.054 · Cited by 47
CD137 (4-1BB) Costimulation Modifies DNA Methylation in CD8+ T Cell–Relevant Genes
Aznar, M. A., Labiano, S., Díaz‐Lagares, Á., Molina, C., Garasa, S., Azpilikueta, A., Etxeberría, I., Sánchez-Paulete, A. R., Korman, A. J., Esteller, M., et al. (2017) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-17-0159 · Cited by 44
Tfh1 Cells in Germinal Centers During Chronic HIV/SIV Infection
Velu, V., Mylvaganam, G., Ibegbu, C., & Amara, R. R. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01272 · Cited by 43
Effects of Csf1R-Targeted Chimeric Antigen Receptor-Modified Nk92Mi & T Cells on Tumor-Associated Macrophages
Zhang, P., Zhao, S., Wu, C., Li, J., Li, Z., Wen, C., Hu, S., An, G., Meng, H., Zhang, X., et al. (2018) · Immunotherapy · doi:10.2217/imt-2018-0012 · Cited by 44
PD-1 blockade and vaccination provide therapeutic benefit against SIV by inducing broad and functional CD8 + T cells in lymphoid tissue
Rahman, S. A., Yagnik, B., Bally, A. P. R., Morrow, K. N., Wang, S., Vanderford, T. H., Freeman, G. J., Ahmed, R., & Amara, R. R. (2021) · Science Immunology · doi:10.1126/sciimmunol.abh3034 · Cited by 43
Self-citation
Clinical outcome following checkpoint therapy in renal cell carcinoma is associated with a burst of activated CD8 T cells in blood
Carlisle, J. W., Jansen, C. S., Cardenas, M. A., Sobierajska, E., Reyes, A. M., Greenwald, R., del Balzo, L., Prokhnevska, N., Küçük, Ö., Carthon, B. C., et al. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-004803 · Cited by 42
Self-citation
HMGB2 regulates the differentiation and stemness of exhausted CD8+ T cells during chronic viral infection and cancer
Neubert, E. N., DeRogatis, J. M., Lewis, S. A., Viramontes, K. M., Ortega, P., Henriquez, M. L., Buisson, R., Messaoudi, I., & Tinoco, R. (2023) · Nature Communications · doi:10.1038/s41467-023-41352-0 · Cited by 45
Platinum-Based Chemotherapy Attenuates the Effector Response of CD8 T Cells to Concomitant PD-1 Blockade
Mariniello, A., Nasti, T. H., Chang, D. Y., Hashimoto, M., Malik, S., McManus, D. T., Lee, J., McGuire, D. J., Cardenas, M. A., Umaña, P., et al. (2023) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-23-1316 · Cited by 46
Self-citation
Multi-omics Analysis Reveals Immune Features Associated with Immunotherapy Benefit in Patients with Squamous Cell Lung Cancer from Phase III Lung-MAP S1400I Trial
Parra, E. R., Zhang, J., Duose, D. Y., Gonzalez‐Kozlova, E., Redman, M. W., Chen, H., Manyam, G. C., Kumar, G., Zhang, J., Song, X., et al. (2024) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-23-0251 · Cited by 43
Self-citation
B cells and the coordination of immune checkpoint inhibitor response in patients with solid tumors
Flippot, R., Teixeira, M., Rey-Cárdenas, M., Carril-Ajuria, L., Rainho, L., Naoun, N., Jouniaux, J.-M., Boselli, L., Naigeon, M., Danlos, F., et al. (2024) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2023-008636 · Cited by 47
T cell exhaustion in human cancers
Kang, K., Lin, X., Chen, P., Liu, H., Liu, F., Xiong, W., Li, G., Yi, M., Li, X., Wang, H., et al. (2024) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2024.189162 · Cited by 49
Viral-specific T-cell transfer from HSCT donor for the treatment of viral infections or diseases after HSCT
Qian, C., Wang, Y., Reppel, L., D’Aveni, M., Campidelli, A., Decot, V., & Bensoussan, D. (2017) · Bone Marrow Transplantation · doi:10.1038/bmt.2017.232 · Cited by 42
CXCR5 and ICOS expression identifies a CD8 T-cell subset with TFH features in Hodgkin lymphomas
Le, K.-S., Amé-Thomas, P., Tarte, K., Gondois‐Rey, F., Granjeaud, S., Orlanducci, F., Foucher, E. D., Broussais, F., Bouabdallah, R., Fest, T., et al. (2018) · Blood Advances · doi:10.1182/bloodadvances.2018017244 · Cited by 44
An Optimized Full-Length FLT3/CD3 Bispecific Antibody Demonstrates Potent Anti-leukemia Activity and Reversible Hematological Toxicity
Yeung, Y. A., Krishnamoorthy, V., Dettling, D. E., Sommer, C., Poulsen, K., Ni, I., Pham, A. T., Chen, W., Liao-Chan, S., Lindquist, K. C., et al. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2019.12.014 · Cited by 42
PD-L1/L2 protein levels rapidly increase on monocytes via trogocytosis from tumor cells in classical Hodgkin lymphoma
Kawashima, M., Carreras, J., Higuchi, H., Kotaki, R., Hoshina, T., Okuyama, K., Suzuki, N., Kakizaki, M., Miyatake, Y., Ando, K., et al. (2020) · Leukemia · doi:10.1038/s41375-020-0737-9 · Cited by 45
Self-Assembled Multivalent Aptamer Nanoparticles with Potential CAR-like Characteristics Could Activate T Cells and Inhibit Melanoma Growth
Bai, C., Gao, S., Hu, S., Liu, X., Li, H., Dong, J., Huang, A., Zhu, L., Zhou, P., Li, S., et al. (2020) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2020.03.002 · Cited by 42
Effect of radiotherapy on T cell and PD-1 / PD-L1 blocking therapy in tumor microenvironment
Chen, C., Liu, Y., & Cui, B. (2021) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2020.1840254 · Cited by 43
Anti-PD-1/Anti-PD-L1 Drugs and Radiation Therapy: Combinations and Optimization Strategies
Boustani, J., Lecoester, B., Baude, J., Latour, C., Adotévi, O., Mirjolet, C., & Truc, G. (2021) · Cancers · doi:10.3390/cancers13194893 · Cited by 44
Role of the tumor immune microenvironment in tumor immunotherapy (Review)
Zhou, C., Liu, Q., Xiang, Y., Gou, X., & Li, W. (2021) · Oncology Letters · doi:10.3892/ol.2021.13171 · Cited by 42

Authors: Im, S. J., Hashimoto, M., Gerner, M. Y., Lee, J., Kissick, H. T., Burger, M. C., Shan, Q., Hale, J. S., Lee, J., Nasti, T. H., Sharpe, A. H., Freeman, G. J., Germain, R. N., Nakaya, H. I., Xue, H.-H., & Ahmed, R.
Affiliations: Emory University (US)
National Institutes of Health (US)
University of Iowa (US)
Brigham and Women's Hospital (US)
Harvard University (US)
Universidade de São Paulo (BR)
Corresponding author: Ahmed, Rafi
ORCID: Im, Se Jin
Hashimoto, Masao
Gerner, Michael Y.
Lee, Junghwa
Kissick, Haydn T.
Shan, Qiang
Hale, J. Scott
Lee, Judong
Nasti, Tahseen H.
Sharpe, Arlene H.
Freeman, Gordon J.
Germain, Ronald N.
Nakaya, Helder I.
Xue, Hai-Hui
Ahmed, Rafi
Venue: Nature
Publisher: Springer Science and Business Media LLC
Published: 2016-08-02
Volume: 537
Issue: 7620
Pages: 417-421
ISSN: 0028-0836 (ISSN-L)
1476-4687
DOI: 10.1038/nature19330
PMC: PMC5297183
OpenAlex: W2506616866
Cited by: 2,070
References: 37
Citations by year: 2026: 224 · 2025: 245 · 2024: 268 · 2023: 264 · 2022: 248 · 2021: 252 · 2020: 223 · 2019: 154 · 2018: 101 · 2017: 75 · 2016: 13
FWCI: 69.19
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: Nature (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
RePEc: Research Papers in Economics (submittedVersion)
Funders: National Institutes of Health (n01ai30048-10-0-1)
National Institute of Allergy and Infectious Diseases (N01 AI030048, P01AI080192, P01AI056299, R01AI030048, R01AI121080, R01AI112579)
Topics: Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
Keywords: CD8+ T cells, PD-1, T cell exhaustion, lymphocytic choriomeningitis virus, chronic viral infection, B cell follicles, T follicular helper cells, PD-L1 blockade, anti-PD-1 therapy, HIV, virus control, costimulatory molecules
MeSH terms: Cell Self Renewal, Animals, Cell Differentiation, Female, T-Lymphocytes, Helper-Inducer, Hematopoietic Stem Cells, Immunotherapy, Lymphocytic Choriomeningitis, Lymphocytic choriomeningitis virus, T-Lymphocyte Subsets, CD28 Antigens, CD8-Positive T-Lymphocytes, Cell Proliferation, Mice, Hepatocyte Nuclear Factor 1-alpha, Inducible T-Cell Co-Stimulator Protein, Programmed Cell Death 1 Receptor

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks